GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Oct 30, 2026 (in 35 days)
Similar opportunities open now
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Same funderOpenNational Institutes of HealthCloses Oct 30, 2026 (in 35 days)Up to $2.3M
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 30, 2026 (in 35 days)Up to $1.3M
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jul 2029Up to $500K
Classification and identifiers
- Solicitation number
- RFA-HG-27-013
- Assistance listing (CFDA)
- 93.172
Amount
Amount not published by the funder
Who can apply
Nonprofits, including small and volunteer-run organizations, Small businesses, and Private colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.